Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
组织细胞增多症
病理
组织细胞肉瘤
恶性组织细胞增多症
窦组织细胞增生伴大量淋巴结病变
作者
Hind Salama,Abdul Rahman Jazieh,Ayman Alhejazi,Ahmed Absi,Saeed Alshieban,Mohsen Alzahrani,Ahmed Alaskar,Giamal Gmati,Moussab Damlaj,Khadega A. Abuelgasim,Abdulrahman Alghamdi,Bader Alahmari,Areej Almugairi,Hazza A Alzahrani,Ali Bazarbachi,M.O.H. Musa,Gaurav Goyal
Histiocytic disorders are an exceptionally rare group of diseases with diverse manifestations and a paucity of approved treatments, thereby leading to various challenges in their diagnosis and management. With the discovery of novel molecular targets and the incorporation of targeted agents in the management of various adult histiocytic disorders, their management has become increasingly complex. In an attempt to improve the understanding of the clinical features and management of common adult histiocytic disorders (Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis), we created this document based on existing literature and expert opinion.